Skip to main content
. 2013 Jan 25;11:19. doi: 10.1186/1477-7819-11-19

Table 2.

General and clinicopathological characteristics of patients (n = 120)

Groups Experimental group
 Control group
 P value
Frequency Percentage (%) Frequency Percentage (%)
Gender
 Male
 49
 81.67
 44
 73.33
 0.274a
Female
 11
 18.33
 16
 26.67
Diagnosis
 Colon cancer metastases
 6
 10
 6
 10
 0.066a
Postoperative colon cancer
 8
 13.33
 11
 18.33
Gastric cancer metastases
 4
 6.67
 3
 5
Postoperative gastric cancer
 32
 53.33
 17
 28.33
Rectal cancer metastases
 3
 5
 7
 11.67
Postoperative rectal cancer
 7
 11.67
 16
 26.67
First-line therapy
 No
 44
 73.33
 43
 71.67
 0.838a
Yes
 16
 26.67
 17
 28.33
Smoking
 No
 38
 63.33
 39
 65.00
 0.849a
Yes
 22
 36.67
 21
 35.00
Drinking
 No
 46
 76.67
 40
 66.67
 0.224a
Yes
 14
 23.33
 20
 33.33
Diabetes
 No
 51
 85.00
 54
 90.00
 0.408a
Yes
 9
 15.00
 6
 10.00
Chemotherapy regimen
 FOLFOX4
 13
 21.67
 20
 33.33
 0.152a
XELOX
 47
 78.33
 40
 66.67
Clinical evaluation CR
 1
 1.67
 1
 1.67
 ndb
PD
 2
 3.33
 3
 5.00
PR
 7
 11.67
 3
 5.00
SD
 6
 10.00
 10
 16.67
Assistance 44 73.33 43 71.67

aComparisons performed using χ2 test; bThe sample number is small and comparisons are not done. CR, Complete Response;nd, not done; PD,Progressive Disease; PR, Partial Response;SD,Stable Disease.